MedTrace Logo

Effect of Rosuvastatin in Intracerebral Hemorrhage

NCT00364559 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2009-03-26

No results posted yet for this study

Summary

The purpose of this study is to determine whether rosuvastatin is effective in the management of acute phase of intracerebral hemorrhage and if it impact outcome by NIHSS.

Conditions

  • Intracerebral Hemorrhage
  • Stroke

Interventions

DRUG

Rosuvastatin

20 mg 10 days daily

Sponsors & Collaborators

  • Universidad Autonoma de San Luis Potosí

    lead OTHER

Principal Investigators

  • Ildefonso Rodríguez-Leyva, Neurology · Neurología, Hospital Central "Dr. ignacio Morones Prieto"

  • Humberto Tapia-Perez, MD · Facultad de Medicina UASLP

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-08-31
Primary Completion
2006-12-31
Completion
2006-12-31

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00364559 on ClinicalTrials.gov